Literature DB >> 21609374

Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.

Seth J Karp1, Scott Johnson, Amy Evenson, Michael P Curry, Diarmuid Manning, Raza Malik, Gerond Lake-Bakaar, Michelle Lai, Douglas Hanto.   

Abstract

BACKGROUND: An important issue in the transplantation of livers procured from cardiac death donors (CDDs) concerns why some centres report equivalent outcomes and others report inferior outcomes in transplantations using CDD organs compared with standard criteria donor (SCD) organs. Resolving this discrepancy may increase the number of usable organs.
OBJECTIVES: This study aimed to test whether differences in cold ischaemic time (CIT) are critical during CDD organ transplantation and whether such differences might explain the disparate outcomes.
METHODS: Results of CDD liver transplants in our own centre were compared retrospectively with results in a matched cohort of SCD liver recipients. Endpoints of primary non-function (PNF) and ischaemic cholangiopathy (IC) were used because these outcomes are clearly associated with CDD organ use.
RESULTS: In 22 CDD organ transplants, CIT was a strong predictor of PNF or IC (P = 0.021). Minimising CIT in CDD organ transplants produced outcomes similar to those in a matched SCD organ transplant cohort at our centre and in SCD organ transplant results nationally (1- and 3-year graft and patient survival rates: 90.9% and 73.3% vs. 77.6% and 69.2% in CDD and SCD grafts, respectively. A review of the published literature demonstrated that centres with higher CITs tend to have higher rates of PNF or IC (correlation coefficient: 0.41).
CONCLUSIONS: These findings suggest that a targeted effort to minimise CIT might improve outcomes and allow the safer use of CDD organs.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21609374      PMCID: PMC3103098          DOI: 10.1111/j.1477-2574.2011.00307.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  26 in total

1.  Non-heart-beating organ donation: a defense of the required determination of death.

Authors:  James DuBois
Journal:  J Law Med Ethics       Date:  1999       Impact factor: 1.718

2.  Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.

Authors:  R Mateo; Y Cho; G Singh; M Stapfer; J Donovan; J Kahn; T-L Fong; L Sher; N Jabbour; S Aswad; R R Selby; Y Genyk
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

3.  Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death.

Authors:  M D Doshi; L G Hunsicker
Journal:  Am J Transplant       Date:  2006-10-25       Impact factor: 8.086

4.  Donation after cardiac death as a strategy to increase deceased donor liver availability.

Authors:  Robert M Merion; Shawn J Pelletier; Nathan Goodrich; Michael J Englesbe; Francis L Delmonico
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

5.  Donation after cardiac death: the University of Wisconsin experience with liver transplantation.

Authors:  David P Foley; Luis A Fernandez; Glen Leverson; L Thomas Chin; Nancy Krieger; Jeffery T Cooper; Brian D Shames; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Hans W Sollinger; Munci Kalayoglu; Anthony M D'Alessandro
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

6.  Ischemic-type biliary complications after orthotopic liver transplantation.

Authors:  L Sanchez-Urdazpal; G J Gores; E M Ward; T P Maus; H E Wahlstrom; S B Moore; R H Wiesner; R A Krom
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

7.  Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007.

Authors:  Olivier Detry; Vincent Donckier; Valerio Lucidi; Dirk Ysebaert; Thiery Chapelle; Jan Lerut; Olga Ciccarelli; Jacques Pirenne; Diethard Monbaliu; Arnaud De Roover; Pierre Honoré; Xavier Rogiers; Bernard De Hemptinne; Roberto Troisi
Journal:  Transpl Int       Date:  2009-12-14       Impact factor: 3.782

8.  Characteristics associated with liver graft failure: the concept of a donor risk index.

Authors:  S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

9.  Donation after cardiac death: the University of Wisconsin experience.

Authors:  Anthony M D'Alessandro; Luis A Fernandez; L Thomas Chin; Brian D Shames; Nicole A Turgeon; David L Scott; Antonio Di Carlo; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Robert B Love; John D Pirsch; Bryan N Becker; Alexandru I Musat; Munci Kalayoglu; Hans W Sollinger
Journal:  Ann Transplant       Date:  2004       Impact factor: 1.530

10.  Long-term outcome of controlled, non-heart-beating donor liver transplantation.

Authors:  Cosme Y Manzarbeitia; Jorge A Ortiz; Hoonbae Jeon; Kenneth D Rothstein; Oscar Martinez; Victor R Araya; Santiago J Munoz; David J Reich
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

View more
  8 in total

1.  Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

Authors:  Leigh Anne Dageforde; Irene D Feurer; C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2012-07-04       Impact factor: 3.647

2.  Incidence and risk factors for early renal dysfunction after liver transplantation.

Authors:  Patricia Wiesen; Paul B Massion; Jean Joris; Olivier Detry; Pierre Damas
Journal:  World J Transplant       Date:  2016-03-24

3.  Post-reperfusion hydrogen gas treatment ameliorates ischemia reperfusion injury in rat livers from donors after cardiac death: a preliminary study.

Authors:  Takahisa Ishikawa; Shingo Shimada; Moto Fukai; Taichi Kimura; Kouhei Umemoto; Kengo Shibata; Masato Fujiyoshi; Sunao Fujiyoshi; Takahiro Hayasaka; Norio Kawamura; Nozomi Kobayashi; Tsuyoshi Shimamura; Akinobu Taketomi
Journal:  Surg Today       Date:  2018-07-06       Impact factor: 2.549

4.  Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.

Authors:  E K H Chow; A B Massie; X Luo; C E Wickliffe; S E Gentry; A M Cameron; D L Segev
Journal:  Am J Transplant       Date:  2016-08-24       Impact factor: 8.086

Review 5.  Progress in abdominal organ transplantation.

Authors:  Maciej Kosieradzki; Wojciech Lisik; Wojciech Rowiński; Piotr Małkowski
Journal:  Med Sci Monit       Date:  2011-12

6.  Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers.

Authors:  Ryota Masuzaki; Hui Yu; Philip Kingsley; Lawrence Marnett; Zhongming Zhao; Seth J Karp
Journal:  Transplant Direct       Date:  2015-06-15

7.  Orthotopic liver transplantation from cardiac death donors in the mouse: a new model and evaluation of cardiac death time.

Authors:  Zhenzhen Liu; Ning Pan; Xiangwei Lv; Song Li; Liming Wang; Qinlong Liu
Journal:  Iran J Basic Med Sci       Date:  2017-06       Impact factor: 2.699

Review 8.  Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury.

Authors:  Mónica B Jiménez-Castro; María Eugenia Cornide-Petronio; Jordi Gracia-Sancho; Carmen Peralta
Journal:  Cells       Date:  2019-09-23       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.